Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1989 Apr;66(4):611–615.

Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein.

L L Thomas 1, L M Zheutlin 1, G J Gleich 1
PMCID: PMC1385166  PMID: 2469646

Abstract

Eosinophil granule major basic protein (MBP) is a 13,800 MW arginine-rich polypeptide that is unique among basic molecules in its ability to stimulate human basophil histamine release. We examined the Ca2+ requirements and pharmacological regulation of MBP-stimulated histamine release. Minimal MBP-induced histamine release occurred in the absence of extracellular Ca2+, whereas addition of 0.1 mM Ca2+ resulted in 70% of the maximum histamine release response. Maximum histamine release required 0.5 to 1 mM extracellular Ca2+. The MBP-induced histamine release was blocked by a calmodulin antagonist and by theophylline and was partially inhibited by an inhibitor of phospholipase A2. Release was unaffected by inhibition of protein kinase C. Basophil pretreatment with pertussis toxin also resulted in a concentration-dependent inhibition of release, suggesting involvement of a GTP regulatory protein in the activation mechanism. Histamine release stimulated by a 13,900 MW poly-L-arginine exhibited a dissimilar pharmacological profile from that of MBP. These results support the non-cytolytic nature of the MBP activation mechanism and identify pharmacological approaches for control of MBP-induced mediator release.

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando T., Watanabe S. A new method for fractionation of protamines and the amino acid sequences of salmine and three components of iridine. Int J Protein Res. 1969;1(3):221–224. doi: 10.1111/j.1399-3011.1969.tb01646.x. [DOI] [PubMed] [Google Scholar]
  2. Foreman J. C., Lichtenstein L. M. Induction of histamine secretion by polycations. Biochim Biophys Acta. 1980 May 22;629(3):587–603. doi: 10.1016/0304-4165(80)90164-6. [DOI] [PubMed] [Google Scholar]
  3. Gilman A. G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649. doi: 10.1146/annurev.bi.56.070187.003151. [DOI] [PubMed] [Google Scholar]
  4. Gleich G. J., Adolphson C. R. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177–253. doi: 10.1016/s0065-2776(08)60351-x. [DOI] [PubMed] [Google Scholar]
  5. Grant J. A., Settle L., Whorton E. B., Dupree E. Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol. 1976 Aug;117(2):450–456. [PubMed] [Google Scholar]
  6. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 1984 Oct 9;23(21):5036–5041. doi: 10.1021/bi00316a032. [DOI] [PubMed] [Google Scholar]
  7. Hosey M. M., Lazdunski M. Calcium channels: molecular pharmacology, structure and regulation. J Membr Biol. 1988 Sep;104(2):81–105. doi: 10.1007/BF01870922. [DOI] [PubMed] [Google Scholar]
  8. Lagunoff D., Martin T. W., Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol. 1983;23:331–351. doi: 10.1146/annurev.pa.23.040183.001555. [DOI] [PubMed] [Google Scholar]
  9. Leiferman K. M., Peters M. S., Gleich G. J. The eosinophil and cutaneous edema. J Am Acad Dermatol. 1986 Sep;15(3):513–517. doi: 10.1016/s0190-9622(86)70203-x. [DOI] [PubMed] [Google Scholar]
  10. Lichtenstein L. M., Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science. 1968 Aug 30;161(3844):902–903. doi: 10.1126/science.161.3844.902. [DOI] [PubMed] [Google Scholar]
  11. Lichtenstein L. M. The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J Immunol. 1975 Jun;114(6):1692–1699. [PubMed] [Google Scholar]
  12. Marone G., Columbo M., Poto S., Giugliano R., Condorelli M. Possible role of calmodulin in the control of histamine release from human basophil leukocytes. Life Sci. 1986 Sep 8;39(10):911–922. doi: 10.1016/0024-3205(86)90373-5. [DOI] [PubMed] [Google Scholar]
  13. Marone G., Kagey-Sobotka A., Lichtenstein L. M. Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. Clin Immunol Immunopathol. 1981 Aug;20(2):231–239. doi: 10.1016/0090-1229(81)90181-1. [DOI] [PubMed] [Google Scholar]
  14. Middleton E., Jr, Drzewiecki G., Triggle D. Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol. 1981 Oct;30(20):2867–2869. doi: 10.1016/0006-2952(81)90428-7. [DOI] [PubMed] [Google Scholar]
  15. Mitchell E. B., Crow J., Chapman M. D., Jouhal S. S., Pope F. M., Platts-Mills T. A. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet. 1982 Jan 16;1(8264):127–130. doi: 10.1016/s0140-6736(82)90379-8. [DOI] [PubMed] [Google Scholar]
  16. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  17. O'Donnell M. C., Ackerman S. J., Gleich G. J., Thomas L. L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med. 1983 Jun 1;157(6):1981–1991. doi: 10.1084/jem.157.6.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Olsson I., Venge P. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood. 1974 Aug;44(2):235–246. [PubMed] [Google Scholar]
  19. Olsson I., Venge P., Spitznagel J. K., Lehrer R. I. Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest. 1977 May;36(5):493–500. [PubMed] [Google Scholar]
  20. Peters M. S., Rodriguez M., Gleich G. J. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest. 1986 Jun;54(6):656–662. [PubMed] [Google Scholar]
  21. Saito H., Okajima F., Molski T. F., Sha'afi R. I., Ui M., Ishizaka T. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils. J Immunol. 1987 Jun 1;138(11):3927–3934. [PubMed] [Google Scholar]
  22. Schleimer R. P., Gillespie E., Lichtenstein L. M. Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. J Immunol. 1981 Feb;126(2):570–574. [PubMed] [Google Scholar]
  23. Siraganian R. P. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem. 1974 Feb;57(2):383–394. doi: 10.1016/0003-2697(74)90093-1. [DOI] [PubMed] [Google Scholar]
  24. Slifman N. R., Loegering D. A., McKean D. J., Gleich G. J. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol. 1986 Nov 1;137(9):2913–2917. [PubMed] [Google Scholar]
  25. Solley G. O., Gleich G. J., Jordon R. E., Schroeter A. L. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest. 1976 Aug;58(2):408–420. doi: 10.1172/JCI108485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tanaka T., Ohmura T., Yamakado T., Hidaka H. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives. Mol Pharmacol. 1982 Sep;22(2):408–412. [PubMed] [Google Scholar]
  27. Thueson D. O., Kennedy J. A., Wright C. D., Conroy M. C. Specific inhibition of phorbol ester and DiC8-induced histamine release from human basophils by the protein kinase C inhibitors, H-7 and H-9. Biochem Biophys Res Commun. 1987 Apr 29;144(2):732–740. doi: 10.1016/s0006-291x(87)80026-8. [DOI] [PubMed] [Google Scholar]
  28. Tobin M. C., Karns B. K., Anselmino L. M., Thomas L. L. Potentiation of human basophil histamine release by protamine: a new role for a polycation recognition site. Mol Immunol. 1986 Mar;23(3):245–253. doi: 10.1016/0161-5890(86)90050-7. [DOI] [PubMed] [Google Scholar]
  29. Volwerk J. J., Pieterson W. A., de Haas G. H. Histidine at the active site of phospholipase A2. Biochemistry. 1974 Mar 26;13(7):1446–1454. doi: 10.1021/bi00704a020. [DOI] [PubMed] [Google Scholar]
  30. Warner J. A., Yancey K. B., MacGlashan D. W., Jr The effect of pertussis toxin on mediator release from human basophils. J Immunol. 1987 Jul 1;139(1):161–165. [PubMed] [Google Scholar]
  31. Wasmoen T. L., Bell M. P., Loegering D. A., Gleich G. J., Prendergast F. G., McKean D. J. Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J Biol Chem. 1988 Sep 5;263(25):12559–12563. [PubMed] [Google Scholar]
  32. Zheutlin L. M., Ackerman S. J., Gleich G. J., Thomas L. L. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol. 1984 Oct;133(4):2180–2185. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES